ZA982911B - Drug delivery system for two or more active substances - Google Patents

Drug delivery system for two or more active substances

Info

Publication number
ZA982911B
ZA982911B ZA982911A ZA982911A ZA982911B ZA 982911 B ZA982911 B ZA 982911B ZA 982911 A ZA982911 A ZA 982911A ZA 982911 A ZA982911 A ZA 982911A ZA 982911 B ZA982911 B ZA 982911B
Authority
ZA
South Africa
Prior art keywords
delivery system
drug delivery
active substances
substances
active
Prior art date
Application number
ZA982911A
Other languages
English (en)
Inventor
Rudolf Johannes Jo Groenewegen
Original Assignee
Akzo Nobel Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8228203&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ZA982911(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Akzo Nobel Nv filed Critical Akzo Nobel Nv
Publication of ZA982911B publication Critical patent/ZA982911B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/2853—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers, poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A61K9/0036—Devices retained in the vagina or cervix for a prolonged period, e.g. intravaginal rings, medicated tampons, medicated diaphragms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Reproductive Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gynecology & Obstetrics (AREA)
  • Endocrinology (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ZA982911A 1997-04-11 1998-04-06 Drug delivery system for two or more active substances ZA982911B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP97201098 1997-04-11

Publications (1)

Publication Number Publication Date
ZA982911B true ZA982911B (en) 1998-10-09

Family

ID=8228203

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA982911A ZA982911B (en) 1997-04-11 1998-04-06 Drug delivery system for two or more active substances

Country Status (27)

Country Link
US (1) US5989581A (hu)
EP (1) EP0876815B1 (hu)
JP (2) JP4982670B2 (hu)
KR (1) KR100492676B1 (hu)
CN (1) CN1163222C (hu)
AR (1) AR011709A1 (hu)
AT (1) ATE211646T1 (hu)
AU (1) AU726934B2 (hu)
BR (1) BR9801027B1 (hu)
CA (1) CA2233753C (hu)
CZ (1) CZ294099B6 (hu)
DE (1) DE69803112T2 (hu)
DK (1) DK0876815T3 (hu)
ES (1) ES2171283T3 (hu)
HK (1) HK1016886A1 (hu)
HU (1) HU222343B1 (hu)
ID (1) ID21259A (hu)
IL (2) IL123813A0 (hu)
NO (1) NO320394B1 (hu)
NZ (1) NZ330145A (hu)
PL (1) PL192449B1 (hu)
PT (1) PT876815E (hu)
RU (1) RU2206325C2 (hu)
SG (1) SG65061A1 (hu)
TR (1) TR199800648A1 (hu)
TW (1) TW358031B (hu)
ZA (1) ZA982911B (hu)

Families Citing this family (87)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL123813A0 (en) * 1997-04-11 1998-10-30 Akzo Nobel Nv Drug delivery system for two or more active substances
US6039968A (en) † 1997-06-24 2000-03-21 Hoechst Marion Roussel Intravaginal drug delivery device
US6361780B1 (en) * 1998-11-12 2002-03-26 Cardiac Pacemakers, Inc. Microporous drug delivery system
US6217895B1 (en) 1999-03-22 2001-04-17 Control Delivery Systems Method for treating and/or preventing retinal diseases with sustained release corticosteroids
US6371970B1 (en) 1999-07-30 2002-04-16 Incept Llc Vascular filter having articulation region and methods of use in the ascending aorta
US7369463B1 (en) 2000-02-21 2008-05-06 N.V. Organon Electronic alarm timer for use with a medical regimen
US20040115268A1 (en) * 2000-04-26 2004-06-17 Control Delivery Systems, Inc. Systemic delivery of antiviral agents
US6375972B1 (en) * 2000-04-26 2002-04-23 Control Delivery Systems, Inc. Sustained release drug delivery devices, methods of use, and methods of manufacturing thereof
US6671562B2 (en) 2001-11-09 2003-12-30 Oscor Inc. High impedance drug eluting cardiac lead
TWI297685B (en) 2002-04-04 2008-06-11 Organon Nv Non-steroidal progesterone receptor modulators
US8871241B2 (en) * 2002-05-07 2014-10-28 Psivida Us, Inc. Injectable sustained release delivery devices
JP2005532313A (ja) * 2002-05-07 2005-10-27 コントロール・デリバリー・システムズ・インコーポレイテッド 薬物送達装置の形成方法
DE60332769D1 (de) 2002-11-07 2010-07-08 Organon Nv Indole, die sich zur behandlung von mit dem androgenrezeptor in zusammenhang stehenden krankheiten eignen
US7357046B2 (en) * 2002-12-16 2008-04-15 N. V. Organon Method for dissolution testing of a pharmaceutical delivery device
AU2003298350A1 (en) * 2002-12-16 2004-07-09 Akzo Nobel N.V. Vessel, method and apparatus for dissolution testing of an annular pharmaceutical delivery device
JP4898431B2 (ja) 2003-04-29 2012-03-14 ザ ジェネラル ホスピタル コーポレイション 複数薬物の持続放出のための方法およびデバイス
TWI336627B (en) * 2003-05-23 2011-02-01 Organon Nv Drug delivery system,and use and manufacturing method thereof
MXPA06007852A (es) * 2004-01-15 2007-01-31 Warner Chilcott Co Inc Profarmacos di-esteroidales de estradiol.
CN1906207A (zh) * 2004-01-15 2007-01-31 沃纳奇尔科特公司 乙炔雌二醇的二－甾族前体药物
CN100531800C (zh) * 2004-03-24 2009-08-26 奥尔加侬股份有限公司 基于聚乙烯乙酸乙烯酯共聚物的药物递送系统
TW200531977A (en) 2004-03-25 2005-10-01 Akzo Nobel Nv Progesterone receptor modulators
TW200602317A (en) 2004-04-23 2006-01-16 Akzo Nobel Nv Novel androgens
US20080095822A1 (en) * 2004-11-16 2008-04-24 Universite De Liege Active Substance Delivery System Comprising A Hydrogel Atrix And Microcarriers
CN100366242C (zh) * 2005-01-13 2008-02-06 杭州容立医药科技有限公司 防滑脱阴道药物释放体系及其制造工艺和在制药中的应用
CA2613044A1 (en) * 2005-06-20 2007-01-04 Abbeymoor Medical, Inc. Medicament delivery article, accessory & system
TW200727920A (en) * 2005-06-21 2007-08-01 Organon Nv New regimens for oral monophasic contraceptives
MX2008000416A (es) * 2005-07-12 2008-03-10 Warner Chilcott Co Inc Profarmacos de 3-ester de etinil estradiol.
MX2008000412A (es) * 2005-07-12 2008-03-10 Warner Chilcott Co Inc Profarmacos de 3-ester de estradiol.
CN1899643B (zh) * 2005-07-20 2010-12-29 上海市计划生育科学研究所 含有抗雌激素和抗孕激素复合制剂的阴道环或宫内释药装置及其制药用途
US8801694B2 (en) * 2005-08-11 2014-08-12 Massachusetts Institute Of Technology Intravesical drug delivery device
US20070077269A1 (en) * 2005-10-04 2007-04-05 Woodward John R Method of birth control and hormone regulation
US7989442B2 (en) 2006-09-27 2011-08-02 N.V. Organon Progesterone receptor modulators
AU2007324467A1 (en) * 2006-11-22 2008-05-29 N.V. Organon Vaginal delivery system for mirtazapine
TW200840595A (en) * 2006-12-12 2008-10-16 Organon Nv Oral contraceptive spray
US8063037B2 (en) 2007-05-07 2011-11-22 N. V. Organon Progesterone receptor modulators
TW200930343A (en) * 2007-09-21 2009-07-16 Organon Nv Drug delivery system
EP2231254B9 (en) 2007-12-11 2015-04-08 Massachusetts Institute of Technology Implantable drug delivery device
KR101689786B1 (ko) * 2008-08-09 2016-12-26 메사츄세츠 인스티튜트 어브 테크놀로지 남성 비뇨생식기 및 주위 조직을 치료하는 방법 및 체내이식형 약물 전달 장치
US20100040671A1 (en) * 2008-08-12 2010-02-18 Ahmed Salah U Intravaginal Devices With a Rigid Support, Methods of Making, and Uses Thereof
EP2352544A4 (en) * 2008-11-07 2013-12-25 Combinent Biomedical Systems Inc DEVICES AND METHOD FOR THE TREATMENT AND / OR PREVENTION OF DISEASES
FI121000B (fi) * 2008-11-19 2010-06-15 Bayer Schering Pharma Oy Intravaginaalinen antojärjestelmä ja menetelmä sen valmistamiseksi
UY32492A (es) 2009-03-17 2010-10-29 Organon Nv Dispositivo de suministro de droga zootécnica.
CN102481450B (zh) 2009-04-07 2015-09-16 威斯特天主教保健中心 子宫电刺激系统及方法
US8568374B2 (en) * 2009-05-04 2013-10-29 Merck Sharp & Dohme B.V. Intrauterine system
EP2437684B1 (en) 2009-06-03 2022-06-15 ForSight Vision5, Inc. Anterior segment drug delivery
AU2010265863C1 (en) 2009-06-26 2012-11-01 Taris Biomedical Llc Implantable drug delivery devices and methods of making the same
IN2012DN00711A (hu) 2009-07-21 2015-06-19 Population Council Inc
US9017312B2 (en) 2009-09-10 2015-04-28 Taris Biomedical Llc Implantable device for controlled drug delivery
AU2011238710B2 (en) * 2010-03-28 2015-08-20 Evestra, Inc. Intravaginal drug delivery device
EP2580191A2 (en) 2010-06-10 2013-04-17 The U.S.A. as represented by the Secretary, Department of Health and Human Services Thioether prodrug compositions as anti-hiv and anti-retroviral agents
US8580294B2 (en) 2010-10-19 2013-11-12 International Partnership For Microbicides Platinum-catalyzed intravaginal rings
US9872983B2 (en) 2010-10-27 2018-01-23 Dignity Health Uterine electrical stimulation system and method
WO2012058289A2 (en) 2010-10-27 2012-05-03 Dignity Health Uterine electrical stimulation system and method
JP2014503554A (ja) 2011-01-10 2014-02-13 タリス バイオメディカル，インコーポレイテッド 膀胱痛及び刺激性排尿の持続的治療の使用のためのリドカインレジメン
KR101263916B1 (ko) 2011-01-11 2013-05-13 이장희 성 호르몬 방출 장치 및 이를 이용한 동물 피임 및 발정 유도 방법
CN103379902B (zh) * 2011-02-04 2015-11-25 塔里斯生物医药公司 用于低溶解度药物的控制释放的可植入装置
WO2013013172A1 (en) * 2011-07-20 2013-01-24 The University Of Utah Research Foundation Intravaginal devices for drug delivery
WO2013029194A1 (es) 2011-08-26 2013-03-07 Universidad De Santiago De Chile Uso de los anti-inflamatorios no esteroidales meloxicam y piroxicam, por via intravaginal, para la interrupción del proceso ovulatorio en la mujer
PT2893804T (pt) 2012-09-03 2018-06-26 Ecosea Farming S A Sistema de imersão de um reservatório-jaula destinado à cultura e/ou contenção de espécies hidrobiológicas
CN104797258A (zh) 2012-11-22 2015-07-22 拜耳药业股份公司 包含左炔诺孕酮和cox抑制剂的药物组合物用于按需避孕的用途和施用方法
CN114403811A (zh) 2013-03-08 2022-04-29 里加利私人有限公司 阴道给药和/或诊断系统
CA2903164C (en) 2013-03-15 2024-06-11 Taris Biomedical Llc Drug delivery devices with drug-permeable component and methods
LT3035991T (lt) 2013-08-19 2020-11-10 Taris Biomedical Llc Daugiablokiai vaistų vartojimo įtaisai
WO2015035003A1 (en) 2013-09-05 2015-03-12 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Thioether prodrug compositions as anti-hiv and anti-retroviral agents
WO2015055789A1 (en) 2013-10-17 2015-04-23 Bayer Pharma Aktiengesellschaft INTRAVAGINAL USE OF 18-METHYL-15ß,16ß-METHYLENE-19-NOR-20-SPIROX-4-EN-3-ONES, INTRAVAGINAL RINGS COMPRISING 18-METHYL-15ß,16ß-METHYLENE-19-NOR-20-SPIROX-4-EN-3-ONES, AND USE THEREOF IN CONTRACEPTION
US10137031B2 (en) 2013-11-14 2018-11-27 International Partnership For Microbicides, Inc. Combination therapy intravaginal rings
US10413504B2 (en) 2013-12-11 2019-09-17 Merck Sharp & Dohme Corp. Intravaginal ring drug delivery system
WO2015086489A1 (en) 2013-12-11 2015-06-18 Merck Sharp & Dohme B.V. Drug delivery system for delivery of anti-virals
US10918515B2 (en) 2015-03-31 2021-02-16 Merck Sharp & Dohme B.V. Vaginal ring applicator
WO2016168141A1 (en) 2015-04-13 2016-10-20 Forsight Vision5, Inc. Ocular insert composition of semi-crystalline or crystalline pharmaceutically active agent
US10894150B2 (en) 2015-04-23 2021-01-19 Taris Biomedical Llc Drug delivery devices with drug-permeable component and methods
US11096888B2 (en) 2015-05-13 2021-08-24 Bayer Oy Long acting drug delivery device and its use in contraception
EP3272333A1 (en) 2016-07-22 2018-01-24 Chemo Research, S.L. Vaginal composition comprising a combination of estrogen and vitamin d
EP3395335A1 (en) 2017-04-24 2018-10-31 Kern Pharma, S.L. Vaginal ring for the simultaneous release of two active ingredients
DE102017113166A1 (de) * 2017-06-14 2018-12-20 Amw Gmbh Depotform zur Abgabe eines Östrogen-Wirkstoffs
US11103460B2 (en) 2017-08-07 2021-08-31 Board Of Regents, The University Of Texas System Fabrication methods for nanodelivery systems for long term controlled delivery of active pharmaceutical ingredients
WO2019226519A1 (en) 2018-05-24 2019-11-28 Celanese EVA Performance Polymers Corporation Implantable device for sustained release of a macromolecular drug compound
BR112020023983A2 (pt) 2018-05-24 2021-02-23 Celanese Eva Performance Polymers Llc dispositivo implantável para liberação prolongada de um composto de fármaco macromolecular
MX2021006426A (es) * 2018-12-11 2021-09-14 Lupin Inc Sistema de suministro de farmaco para combinaciones de estrogeno de dosis ultra-baja y metodos y usos del mismo.
US10632066B1 (en) 2019-02-01 2020-04-28 The Population Council, Inc. Method of providing birth control
US10918649B2 (en) 2019-06-21 2021-02-16 The Population Council, Inc. System for providing birth control
US11529308B2 (en) 2019-06-21 2022-12-20 The Population Council, Inc. System for providing birth control
WO2021068239A1 (zh) 2019-10-12 2021-04-15 国家卫生健康委科学技术研究所 用于黄体支持的阴道缓释给药系统及其制备方法与应用
WO2021108722A1 (en) 2019-11-27 2021-06-03 Oak Crest Institute Of Science Sustained release drug delivery device
USD935018S1 (en) 2020-04-07 2021-11-02 The Population Council, Inc. Contraceptive
WO2023133517A1 (en) 2022-01-06 2023-07-13 Oak Crest Institute Of Science Subdermal implant for sustained drug delivery
WO2024115763A1 (en) 2022-12-02 2024-06-06 Vari Bioscience Gmbh Estriol vaginal ring

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3040978A1 (de) * 1980-10-28 1982-05-27 Schering Ag, 1000 Berlin Und 4619 Bergkamen Vaginalring
ZA857643B (en) * 1984-10-12 1986-05-28 Akzo Nv Release system for two or more active substances
US4816258A (en) * 1987-02-26 1989-03-28 Alza Corporation Transdermal contraceptive formulations
DE3879031T2 (de) * 1987-08-08 1993-06-24 Akzo Nv Kontrazeptives implantat.
JPH03123727A (ja) * 1989-10-04 1991-05-27 Nitto Denko Corp 経皮吸収製剤
AU6360896A (en) * 1995-07-04 1997-02-05 Akzo Nobel N.V. Ring-shaped devices
US5906830A (en) * 1995-09-08 1999-05-25 Cygnus, Inc. Supersaturated transdermal drug delivery systems, and methods for manufacturing the same
IL123813A0 (en) * 1997-04-11 1998-10-30 Akzo Nobel Nv Drug delivery system for two or more active substances

Also Published As

Publication number Publication date
JPH10287549A (ja) 1998-10-27
CA2233753C (en) 2001-12-25
BR9801027A (pt) 2000-01-11
IL123813A (en) 2001-11-25
NO981638D0 (no) 1998-04-08
KR100492676B1 (ko) 2005-10-19
KR19980081290A (ko) 1998-11-25
EP0876815B1 (en) 2002-01-09
AU726934B2 (en) 2000-11-23
AR011709A1 (es) 2000-08-30
AU6075198A (en) 1998-10-15
BR9801027B1 (pt) 2009-01-13
US5989581A (en) 1999-11-23
HU9800863D0 (en) 1998-05-28
NO981638L (no) 1998-10-12
HUP9800863A3 (en) 2000-06-28
CZ110298A3 (cs) 1998-10-14
ATE211646T1 (de) 2002-01-15
RU2206325C2 (ru) 2003-06-20
DE69803112T2 (de) 2002-07-18
ID21259A (id) 1999-05-12
CA2233753A1 (en) 1998-10-11
NZ330145A (en) 1999-05-28
JP4982670B2 (ja) 2012-07-25
ES2171283T3 (es) 2002-09-01
HK1016886A1 (en) 1999-11-12
NO320394B1 (no) 2005-11-28
CN1196930A (zh) 1998-10-28
JP2009256378A (ja) 2009-11-05
HU222343B1 (hu) 2003-06-28
SG65061A1 (en) 1999-05-25
DK0876815T3 (da) 2002-04-22
PT876815E (pt) 2002-07-31
EP0876815A1 (en) 1998-11-11
PL192449B1 (pl) 2006-10-31
DE69803112D1 (de) 2002-02-14
HUP9800863A2 (hu) 1999-02-01
PL325774A1 (en) 1998-10-12
TR199800648A1 (xx) 1998-10-21
IL123813A0 (en) 1998-10-30
CZ294099B6 (cs) 2004-10-13
CN1163222C (zh) 2004-08-25
TW358031B (en) 1999-05-11

Similar Documents

Publication Publication Date Title
ZA982911B (en) Drug delivery system for two or more active substances
GB2338414B (en) Intravesical drug delivery system
HUP0001914A3 (en) Biocompatible compounds for pharmaceutical drug delivery systems
EP0981333A4 (en) INNOVATIVE SYSTEM FOR THE ADMINISTRATION OF ACTIVE MEDICINES BY AN ACOUSTIC PROCEDURE
AU7493398A (en) Pulsatile drug delivery system
IL125042A0 (en) Gastrointestinal drug delivery system
AU6140598A (en) Multipathway electronically-controlled drug delivery system
HUP0000299A3 (en) Pharmaceutical formulations for sustained drug delivery
GB9818346D0 (en) Drug dispensing system
EP1061987A4 (en) DEVICE FOR ADMINISTERING A MEDICINAL PRODUCT
EG20670A (en) Active substance delivery system
EP0989878A4 (en) DRUG DELIVERY SYSTEM
ZA97976B (en) Uniform drug delivery theraphy.
AU7201998A (en) Drug delivery system
ZA983169B (en) Pharmaceutical dosage units
EP1021137A4 (en) ARRANGEMENT FOR MEDICINE DELIVERY
IL113793A (en) Transdermal delivery system comprising tiagabine for anti-epileptic drugs
GB9714750D0 (en) Drug delivery device
AU2420997A (en) Oligopeptides for drug delivery
EP0913159A4 (en) DRUG DELIVERY SYSTEM USING GALACTOXYLOGLUCANE
GB9404293D0 (en) Drug delivery system
GB9600471D0 (en) Drug delivery system
GB9700355D0 (en) Drug delivery system
AUPO820797A0 (en) Drug delivery system
GB9800835D0 (en) Drug delivery system